Skip to main content
Article thumbnail
Location of Repository

Thalidomide failed to inhibit angiogenesis and fibrosis in hepatic schistosomiasis of the mouse

By Camila Bi??o Lima, Karen Brasil Iglesias and Zilton de Ara??jo Andrade


The relationship between angiogenesis and fibrosis has been demonstrated in several pathological conditions, one of them being schistosomiasis. To observe whether suppression of angiogenesis would interfere with fibrosis, Thalidomide, an anti-angiogenesis drug, was administered during 30 consecutive days to mice with experimental schistosomiasis. Computerized morphometric measurements of fibrosis, and the counting of blood vessels from hepatic schistosomal lesions did not significantly differ when treated animals and their controls were compared at the end of the experiments. These rather unexpected results are presented under the understanding that they may be of interest during further studies on the anti-angiogenesis properties of thalidomide, and the relationship between angiogenesis and fibrosi

Topics: Thalidomide, Schistosomiasis, Angiogenesis, Fibrosis, Inibidores da Angiog??nese, Cirrose Hep??tica, Neovasculariza????o Patol??gica, Esquistossomose mansoni, F??gado, Modelos Animais de Doen??as, Camundongos
Year: 2007
OAI identifier:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.